Recombinant ROR1 (Zilovertamab Biosimilar) antibody
Quick Overview for Recombinant ROR1 (Zilovertamab Biosimilar) antibody (ABIN7581651)
Target
Antibody Type
Reactivity
Host
Clonality
Conjugate
Application
-
-
Expression System
- CHO Cells
-
Purpose
- Anti-ROR1 Reference Antibody (zilovertamab)
-
Sequence
- QVQLQESGPG LVKPSQTLSL TCTVSGYAFT AYNIHWVRQA PGQGLEWMGS FDPYDGGSSY NQKFKDRLTI SKDTSKNQVV LTMTNMDPVD TATYYCARGW YYFDYWGHGT LVTVSSASTK GPSVFPLAPS SKSTSGGTAA LGCLVKDYFP EPVTVSWNSG ALTSGVHTFP AVLQSSGLYS LSSVVTVPSS SLGTQTYICN VNHKPSNTKV DKKVEPKSCD KTHTCPPCPA PELLGGPSVF LFPPKPKDTL MISRTPEVTC VVVDVSHEDP EVKFNWYVDG VEVHNAKTKP REEQYNSTYR VVSVLTVLHQ DWLNGKEYKC KVSNKALPAP IEKTISKAKG QPREPQVYTL PPSRDELTKN QVSLTCLVKG FYPSDIAVEW ESNGQPENNY KTTPPVLDSD GSFFLYSKLT VDKSRWQQGN VFSCSVMHEA LHNHYTQKSL SLSPGK,DIVMTQTPLS LPVTPGEPAS ISCRASKSIS KYLAWYQQKP GQAPRLLIYS GSTLQSGIPP RFSGSGYGTD FTLTINNIES EDAAYYFCQQ HDESPYTFGE GTKVEIKRTV AAPSVFIFPP SDEQLKSGTA SVVCLLNNFY PREAKVQWKV DNALQSGNSQ ESVTEQDSKD STYSLSSTLT LSKADYEKHK VYACEVTHQG LSSPVTKSFN RGEC
-
Characteristics
- Anti-ROR1 Reference Antibody (zilovertamab) is expressed from CHO. The heavy chain type is huIgG1, and the light chain type is hukappa. It has a predicted MW of 146.14 kDa.
-
Purity
- >95 %
-
Isotype
- IgG1
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Comment
-
Therapeutic Agents by Target and Mechanism: ROR1 antagonist
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Concentration
- 1 mg/mL
-
Buffer
- 25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2
-
Storage
- 4 °C,-80 °C
-
Storage Comment
- +4°C,-80°C
-
-
- ROR1 (Zilovertamab Biosimilar)
-
Target Type
- Biosimilar
-
Molecular Weight
- 146.14 kDa
-
UniProt
- Q01973
Target
-